FDA nod for IOLCP's manufacturing plant

With this approval, IOL Chemicals and Pharmaceuticals (IOLCP) will be able to launch its API business in the American market


The manufacturing facility is located in Barnala, Punjab

IOL Chemicals and Pharmaceuticals (IOLCP) has announced that the company has received establishment inspection report from the US Food and Drug Administration (USFDA) for its Ibuprofen manufacturing facility in Barnala, Punjab.

The company's manufacturing plant already hold CEP certification (certification of suitability) for its product Ibuprofen, Metformin Hydrochloride and Lamotrigine from the European Directorate for the Quality of Medicine and Healthcare (EQDM) authorities, Council of Europe, France. The said facility has also been approved by ANVISA Brazil, WHO and MOH Japan.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email